Welcome to PharmaBusinessDelvelopment.ch

Our ServicesOur Services
From international HQ setup in Switzerland to Company and Business roll out into selected markets in Europe and the Eurasian Union either within the legal framework of our customer or alternatively with proven external partners through our network we provide for and execute a rollout plan which includes the following elements: EMEA Business planning, Market Access and Business Development, Registration and Reimbursement filings, Management of KOLs and Patient Groups, negotiations with governmental bodies, hiring of key personnel, wholesaler and distributor agreements particularly in the area of Oncology, Haematology and Rare Diseases - Orphan Drugs. >> read more...


Industry BackgroundIndustry Background
Over the last decade, there has been a growing number of US Biotech companies, who took the decision to market their newly approved therapies on their own rather than being acquired  by Big Pharma. Excaples include Genentech, Cephalon, Biogen, Celgene, Alexion just to name a few.

As a first step, these Biotech companies introduced their new therapies into the US market. >> read more...

Market Entry

Market Entry
The markets in Central and Eastern Europe have experienced significant growth since the end of the iron curtain some 20 years ago. Almost all of these economies converted to market-based systems and as of today 12 of these countries are part of the European Union. These countries include... >> read more...


Top of Switzerland